Back to User profile » Professor Kevin Harrington

Papers published by Professor Kevin Harrington:


Review

A practical guide to the handling and administration of talimogene laherparepvec in Europe

Harrington KJ, Michielin O, Malvehy J, Pezzani Grüter I, Grove L, Frauchiger AL, Dummer R

OncoTargets and Therapy 2017, 10:3867-3880

Published Date: 2 August 2017

Original Research

Efficacy and safety of talimogene laherparepvec versus granulocyte-macrophage colony-stimulating factor in patients with stage IIIB/C and IVM1a melanoma: subanalysis of the Phase III OPTiM trial

Harrington KJ, Andtbacka RHI, Collichio F, Downey G, Chen L, Szabo Z, Kaufman HL

OncoTargets and Therapy 2016, 9:7081-7093

Published Date: 16 November 2016

Review

Cancer immunotherapy via combining oncolytic virotherapy with chemotherapy: recent advances

Simpson GR, Relph K, Harrington K, Melcher A, Pandha H

Oncolytic Virotherapy 2016, 5:1-13

Published Date: 6 January 2016

Review

Applications of coxsackievirus A21 in oncology

Bradley S, Jakes AD, Harrington K, Pandha H, Melcher A, Errington-Mais F

Oncolytic Virotherapy 2014, 3:47-55

Published Date: 10 April 2014